Aspirin and gastric cancer risk

European Journal of Cancer Prevention

Volumn 19, Issue 6, 2010, Pages 426-427

  Bertuccio, Paola ^a,b   Bravi, Francesca ^a,b   Bosetti, Cristina ^a   Negri, Eva ^a   La Vecchia, Carlo ^a,b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ALCOHOL CONSUMPTION; ANTHROPOMETRIC PARAMETERS; BODY MASS; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER RISK; DEMOGRAPHY; DIET THERAPY; DISEASE ASSOCIATION; DRUG USE; EARLY DIAGNOSIS; FAMILY HISTORY; FEMALE; HISTOPATHOLOGY; HUMAN; LETTER; LIFESTYLE MODIFICATION; MALE; PRIORITY JOURNAL; RISK REDUCTION; SMOKING; STOMACH CANCER;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICARCINOGENIC AGENTS; ASPIRIN; CASE-CONTROL STUDIES; HUMANS; RISK FACTORS; STOMACH NEOPLASMS;

EID: 77958160738     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32833ecbdc     Document Type: Letter

References (15)

1. Akre K, Ekstrom AM, Signorello LB, Hansson LE, Nyren O (2001). Aspirin and risk for gastric cancer: a population-based case-control study in Sweden. Br J Cancer 84:965-968.
2. Bosetti C, Tavani A, Negri E, Trichopoulos D, La Vecchia C (2001). Reliability of data on medical conditions, menstrual and reproductive history provided by hospital controls. J Clin Epidemiol 54:902-906.
3. Bosetti C, Gallus S, La Vecchia C (2006). Aspirin and cancer risk: an updated quantitative review to 2005. Cancer Causes Control 17:871-888.
4. Breslow NE, Day NE (1980). Statistical methods in cancer research. Vol.I. The analysis of case-control studies. Lyon, France: IARC. IARC Sci Publ No. 32.
5. Cuzick J, Otto F, Baron JA, Brown PH, Burn J, Greenwald P, et al. (2009). Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol 10:501-507.
6. Farrow DC, Vaughan TL, Hansten PD, Stanford JL, Risch HA, Gammon MD, et al. (1998). Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 7:97-102.
7. Kelly JP, Rosenberg L, Kaufman DW, Shapiro S (1990). Reliability of personal interview data in a hospital-based case-control study. Am J Epidemiol 131:79-90.
8. Lindblad M, Lagergren J, Garcia Rodriguez LA (2005). Nonsteroidal antiinflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 14:444-450.
9. Lucenteforte E, Scita V, Bosetti C, Bertuccio P, Negri E, La Vecchia C (2008). Food groups and alcoholic beverages and the risk of stomach cancer: a case-control study in Italy. Nutr Cancer 60:577-584.
10. Ratnasinghe LD, Graubard BI, Kahle L, Tangrea JA, Taylor PR, Hawk E (2004). Aspirin use and mortality from cancer in a prospective cohort study. Anticancer Res 24:3177-3184.
11. Schreinemachers DM, Everson RB (1994). Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 5:138-146.
12. Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath CW Jr (1993). Aspirin use and risk of fatal cancer. Cancer Res 53:1322-1327.
13. Tian W, Zhao Y, Liu S, Li X (2010). Meta-analysis on the relationship between nonsteroidal anti-inflammatory drug use and gastric cancer. Eur J Cancer Prev 19:288-298.
14. Yang P, Zhou Y, Chen B, Wan HW, Jia GQ, Bai HL, et al. (2009). Aspirin use and the risk of gastric cancer: a meta-analysis. Dig Dis Sci 55: 1533-1539.
15. Zaridze D, Borisova E, Maximovitch D, Chkhikvadze V (1999). Aspirin protects against gastric cancer: results of a case-control study from Moscow, Russia. Int J Cancer 82:473-476.